734 Impact of elexacaftor/tezacaftor/ivacaftor on clinical outcomes and quality of life in children with cystic fibrosis aged 6–11 years in the real- world setting
Year: 2025
Type: article
Source: Journal of Cystic Fibrosis
Authors: J. Rayment, V. Daccò, F. Ratjen, J. Duckers, A. Solé, P. Azevedo, M. Cipolli, P. Daigneault, M. Imaduddin Ahmed, Q. Do, E. Muller, M. Jennings, S. Sutharsan
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414695084
